Abstract
Aim: To compare safety (immunogenicity) and efficacy of GP40061 insulin glargine (GP-Gla) and Lantus((R)) (Sanofi glargine, Sa-Gla) in people with dia......
小提示:本篇文献需要登录阅读全文,点击跳转登录